Index of artpub/2020/284139/

Owonikoko, Taofeek K
Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC : Primary and Correlative Biomarker Analyses
2020
https://ddd.uab.cat/record/284139